Home [sandbox] K4D COVID-19 Resource Hub

[sandbox] K4D COVID-19 Resource Hub

Sort by: Date tagged Date published

1
…
7
8
9
…
48

176 - 200 of 1176

The engines of SARS-CoV-2 spread

https://api.zotero.org/groups/2494380/items/L37T64SI?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
Roll out of rapid testing could be a 'game changer' for Africa

https://api.zotero.org/groups/2494380/items/VQ5EHISR?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
Estimating the COVID-19 R number: a bargain with the devil? - The Lancet Infectious Diseases

https://api.zotero.org/groups/2494380/items/NRYTUFBP?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
The Challenges of Expanding Rapid Tests to Curb COVID-19

https://api.zotero.org/groups/2494380/items/AAJ3HW64?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
Understanding COVID-19 vaccine efficacy

https://api.zotero.org/groups/2494380/items/2CCHV7D5?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia

https://api.zotero.org/groups/2494380/items/IRKLTVUZ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
Lives vs. Livelihoods Revisited: Should Poorer Countries with Younger Populations Have Equally Strict Lockdowns?

https://api.zotero.org/groups/2494380/items/JFP7TJWB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/27/2020
SeroTracker

https://api.zotero.org/groups/2494380/items/RBQEES6Q?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Financing a Global Public Health Response

https://api.zotero.org/groups/2494380/items/32788GJ4?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
COVID-19 Vaccine Predictions: Estimating the Time Before We Approve Efficacious COVID-19 Vaccines

https://api.zotero.org/groups/2494380/items/WN9YLGZ8?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Mitigating the Economic and Health Impact of COVID-19 across Africa

https://api.zotero.org/groups/2494380/items/3R72VYL3?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
COVID-19 in Pakistan: A Phone Survey to Assess Education, Economic, and Health-Related Outcomes

https://api.zotero.org/groups/2494380/items/CY38QZVQ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Genomic evidence for reinfection with SARS-CoV-2: a case study

https://api.zotero.org/groups/2494380/items/R83IHB4A?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results

https://api.zotero.org/groups/2494380/items/4ZJ6A4ZW?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

https://api.zotero.org/groups/2494380/items/2TYSNXXB?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

https://api.zotero.org/groups/2494380/items/EELCS9DL?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science

https://api.zotero.org/groups/2494380/items/AHMZV835?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Emerging Evidence on Shielding Vulnerable Groups During COVID-19

https://api.zotero.org/groups/2494380/items/5KJFWNCW?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Community engagement for COVID-19 prevention and control: a rapid evidence synthesis

https://api.zotero.org/groups/2494380/items/B4T2KCYV?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Broader Health Impacts of Vertical Responses to COVID-19 in Low- and Middle- Income Countries (LMICs)

https://api.zotero.org/groups/2494380/items/GKW3BAXN?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
From Overall Fiscal Space to Budgetary Space for Health: Connecting Public Financial Management to Resource Mobilization in the Era of COVID-19

https://api.zotero.org/groups/2494380/items/QXEV5YII?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis

https://api.zotero.org/groups/2494380/items/6KDUWIG9?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
A promising inactivated whole-virion SARS-CoV-2 vaccine

https://api.zotero.org/groups/2494380/items/4S43DZGK?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Bridging Health Gaps With Inclusive Urbanization | Think Global Health

https://api.zotero.org/groups/2494380/items/63YH23YK?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020
Three Lessons from a New Phone Survey in Pakistan

https://api.zotero.org/groups/2494380/items/GH62XE3J?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 10/25/2020

1
…
7
8
9
…
48

176 - 200 of 1176